Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AbbVie
Scientific Title
A Phase 1 Dose Escalation, Open-Label Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma